399 related articles for article (PubMed ID: 24389668)
21. Inhibitory profile of a LEDGF/p75 peptide against HIV-1 integrase: insight into integrase-DNA complex formation and catalysis.
Al-Mawsawi LQ; Christ F; Dayam R; Debyser Z; Neamati N
FEBS Lett; 2008 Apr; 582(10):1425-30. PubMed ID: 18331842
[TBL] [Abstract][Full Text] [Related]
22. Structural basis for the potent inhibition of the HIV integrase-LEDGF/p75 protein-protein interaction.
Ribone SR; Quevedo MA
J Mol Graph Model; 2017 Aug; 75():189-198. PubMed ID: 28582696
[TBL] [Abstract][Full Text] [Related]
23. Chromatinized templates reveal the requirement for the LEDGF/p75 PWWP domain during HIV-1 integration in vitro.
Botbol Y; Raghavendra NK; Rahman S; Engelman A; Lavigne M
Nucleic Acids Res; 2008 Mar; 36(4):1237-46. PubMed ID: 18174227
[TBL] [Abstract][Full Text] [Related]
24. Measuring protein-protein interactions inside living cells using single color fluorescence correlation spectroscopy. Application to human immunodeficiency virus type 1 integrase and LEDGF/p75.
Maertens G; Vercammen J; Debyser Z; Engelborghs Y
FASEB J; 2005 Jun; 19(8):1039-41. PubMed ID: 15788449
[TBL] [Abstract][Full Text] [Related]
25. D77, one benzoic acid derivative, functions as a novel anti-HIV-1 inhibitor targeting the interaction between integrase and cellular LEDGF/p75.
Du L; Zhao Y; Chen J; Yang L; Zheng Y; Tang Y; Shen X; Jiang H
Biochem Biophys Res Commun; 2008 Oct; 375(1):139-44. PubMed ID: 18691555
[TBL] [Abstract][Full Text] [Related]
26. Insight into the inhibitory mechanism and binding mode between D77 and HIV-1 integrase by molecular modeling methods.
Li P; Tan JJ; Liu M; Zhang XY; Chen WZ; Wang CX
J Biomol Struct Dyn; 2011 Oct; 29(2):311-23. PubMed ID: 21875151
[TBL] [Abstract][Full Text] [Related]
27. Discovery of novel inhibitors of LEDGF/p75-IN protein-protein interactions.
Sanchez TW; Debnath B; Christ F; Otake H; Debyser Z; Neamati N
Bioorg Med Chem; 2013 Feb; 21(4):957-63. PubMed ID: 23306052
[TBL] [Abstract][Full Text] [Related]
28. Traditional Chinese medicine application in HIV: an in silico study.
Huang HJ; Jian YR; Chen CY
J Biomol Struct Dyn; 2014; 32(1):1-12. PubMed ID: 23252879
[TBL] [Abstract][Full Text] [Related]
29. L368F/V408F double mutant of IBD of LEDGF/p75 retains interaction with M178I mutant of HIV-1 integrase.
George A; Raghavendra NK
Biochem Biophys Res Commun; 2017 Aug; 490(2):271-275. PubMed ID: 28610923
[TBL] [Abstract][Full Text] [Related]
30. Structure-based mutagenesis of the integrase-LEDGF/p75 interface uncouples a strict correlation between in vitro protein binding and HIV-1 fitness.
Rahman S; Lu R; Vandegraaff N; Cherepanov P; Engelman A
Virology; 2007 Jan; 357(1):79-90. PubMed ID: 16959283
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of a flavonoid library for inhibition of interaction of HIV-1 integrase with human LEDGF/p75 towards a structure-activity relationship.
Yin ZH; Yan HL; Pan Y; Zhang DW; Yan X
Ann Med; 2022 Dec; 54(1):1590-1600. PubMed ID: 35658757
[No Abstract] [Full Text] [Related]
32. Study of Structure-active Relationship for Inhibitors of HIV-1 Integrase LEDGF/p75 Interaction by Machine Learning Methods.
Li Y; Wu Y; Yan A
Mol Inform; 2017 Jul; 36(7):. PubMed ID: 28244220
[TBL] [Abstract][Full Text] [Related]
33. Identification and characterization of the chromatin-binding domains of the HIV-1 integrase interactor LEDGF/p75.
Llano M; Vanegas M; Hutchins N; Thompson D; Delgado S; Poeschla EM
J Mol Biol; 2006 Jul; 360(4):760-73. PubMed ID: 16793062
[TBL] [Abstract][Full Text] [Related]
34. Identification of old drugs as potential inhibitors of HIV-1 integrase - human LEDGF/p75 interaction via molecular docking.
Hu G; Li X; Sun X; Lu W; Liu G; Huang J; Shen X; Tang Y
J Mol Model; 2012 Dec; 18(12):4995-5003. PubMed ID: 22733274
[TBL] [Abstract][Full Text] [Related]
35. Discovery of a novel 5-carbonyl-1H-imidazole-4-carboxamide class of inhibitors of the HIV-1 integrase-LEDGF/p75 interaction.
Serrao E; Xu ZL; Debnath B; Christ F; Debyser Z; Long YQ; Neamati N
Bioorg Med Chem; 2013 Oct; 21(19):5963-72. PubMed ID: 23985689
[TBL] [Abstract][Full Text] [Related]
36. Transient and stable knockdown of the integrase cofactor LEDGF/p75 reveals its role in the replication cycle of human immunodeficiency virus.
Vandekerckhove L; Christ F; Van Maele B; De Rijck J; Gijsbers R; Van den Haute C; Witvrouw M; Debyser Z
J Virol; 2006 Feb; 80(4):1886-96. PubMed ID: 16439544
[TBL] [Abstract][Full Text] [Related]
37. Optimization of rhodanine scaffold for the development of protein-protein interaction inhibitors.
Ferro S; De Luca L; Agharbaoui FE; Christ F; Debyser Z; Gitto R
Bioorg Med Chem; 2015 Jul; 23(13):3208-14. PubMed ID: 25999203
[TBL] [Abstract][Full Text] [Related]
38. The evaluation of statins as potential inhibitors of the LEDGF/p75-HIV-1 integrase interaction.
Harrison AT; Kriel FH; Papathanasopoulos MA; Mosebi S; Abrahams S; Hewer R
Chem Biol Drug Des; 2015 Mar; 85(3):290-5. PubMed ID: 24954548
[TBL] [Abstract][Full Text] [Related]
39. Implication of serine residues 271, 273, and 275 in the human immunodeficiency virus type 1 cofactor activity of lens epithelium-derived growth factor/p75.
Garcia-Rivera JA; Bueno MT; Morales E; Kugelman JR; Rodriguez DF; Llano M
J Virol; 2010 Jan; 84(2):740-52. PubMed ID: 19889764
[TBL] [Abstract][Full Text] [Related]
40. Biochemical and genetic analyses of integrase-interacting proteins lens epithelium-derived growth factor (LEDGF)/p75 and hepatoma-derived growth factor related protein 2 (HRP2) in preintegration complex function and HIV-1 replication.
Vandegraaff N; Devroe E; Turlure F; Silver PA; Engelman A
Virology; 2006 Mar; 346(2):415-26. PubMed ID: 16337983
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
